Hear from industry insiders and their attorneys on the impact of the Covid Pandemic on the cannabis industry and the associated legal landscape. Our experts will explore the opportunities presented by the anticipated distressed asset market, including options for struggling operators, as well as the newly created barriers to entry (e.g., licensing delays, supply shortages, distribution chain closures).

Hear the insights and expectations of Jim Boland, Senior Counsel, Cresco Labs, Daniel Garfield, Founder, McAllister Garfield, P.C., and Eli Korer, Chief Legal Officer, Union Cannabis Group. These industry leaders will discuss the impact of the Covid-19 Pandemic on the cannabis industry and the associated legal landscape.

The exciting topics to consider and explore will include the distressed asset market, anticipated market consolidation (increased M&A activity, joint ventures, and acquisitions), the active investor market, and barriers to entry (e.g., licensing and application delays, credit-crunch, suspension of legalization efforts). Our experts will also focus on options for struggling operators (bankruptcy is not a viable option) and the advantages to existing companies and larger entities. Do we see a downturn in this nascent industry or expansion as states seek new revenue streams? What is the status of the SAFE Banking Act and how does one navigate current banking restrictions? Lastly, we will explore insurance problems and implications for marijuana-related business, especially tenants and building owners.